Walter M Stadler

发表

Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced–MRI analysis

Aytekin Oto, Gregory S Karczmar, Milica Medved, 2009, Magnetic resonance in medicine.

Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations

Gregory S Karczmar, Milica Medved, Cheng Yang, 2004, Magnetic resonance in medicine.

Multiple reference tissue method for contrast agent arterial input function estimation

Gregory S Karczmar, Milica Medved, Cheng Yang, 2007, Magnetic resonance in medicine.

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

Apurva A Desai, Walter M Stadler, M. Gore, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Gregory Karczmar, Milica Medved, Walter M Stadler, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Walter M Stadler, Mark J Ratain, Thomas R Fleming, 2008, European journal of cancer.

Sorafenib in advanced clear-cell renal-cell carcinoma.

Apurva A Desai, Walter M Stadler, Scott Freeman, 2007, The New England journal of medicine.

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Oliver Sartor, Susan Halabi, Lawrence H Schwartz, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Aytekin Oto, Yulei Jiang, Gregory Karczmar, 2010, Radiology.

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

Bruce Montgomery, Javed Siddiqui, Walter M Stadler, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of quantitative parameters in cervix cancer measured by dynamic contrast–enhanced MRI and CT

Ivan Yeung, Gregory S Karczmar, Masoom A Haider, 2010, Magnetic resonance in medicine.

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.

Michael L Maitland, Walter M Stadler, Mark J Ratain, 2007, Journal of the National Cancer Institute.

Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time

Milica Medved, Walter M Stadler, James Dignam, 2004, Journal of magnetic resonance imaging : JMRI.

Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.

Manuel Hidalgo, Donna K Slonim, Walter M Stadler, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)

Walter M Stadler, David C. Smith, Roberto Pili, 2009, Cancer.

A Phase II trial of suramin monthly × 3 for hormone‐refractory prostate carcinoma

Walter M Stadler, Mark J Ratain, Nicholas J Vogelzang, 2004, Cancer.

FYN is overexpressed in human prostate cancer

Ravi Salgia, Javed Siddiqui, Walter M Stadler, 2009, BJU international.